Vivance

Changing Kidney Care Forever |

Singapore, Singapore · Founded 2007 · $60.0M raised

Headquarters
Singapore
Employees
51–200
Founded
2007
Business Model
B2B
Total Funding
$60.0M
Last Round
$20.0M Series BSep 2023
Rounds
2

Totals include recorded grants and other qualifying funding, not just equity. What counts toward funding.

About

Vivance (formerly AWAK Technologies) is a Singapore-based medical technology company on a mission to enhance the lives of people with kidney disease and their caregivers through portable, patient-centric renal technologies. Its product pipeline includes wearable and home-based peritoneal dialysis devices powered by proprietary sorbent technology, as well as an AI-driven model for predicting kidney disease progression — the latter earning two FDA Breakthrough Device Designations. All products are currently in R&D and clinical trial phases, with the company having completed a pre-pivotal clinical trial in partnership with Singapore General Hospital.

Summary

Vivance is a Biotech company based in Singapore, Singapore, founded in 2007. It has raised $60.0M in total across 2 rounds, most recently a $20.0M Series B round in Sep 2023.

Tech & App Stack

3 technologies & apps tracked

Every product and vendor across these categories, with where each signal came from.

Create a free account with 25 free credits every month, no card needed, to unlock the full tech & app stack, funding history, and valuations.

Funding History

Series BSeries BSep 2023
$20.0M

Sign up to see all 2 events

Funding: Venture Round through Series B. Amounts, valuations, and investors where available.

Similar Companies

Pharmaceutical Product Development, Inc. (PPD)Acquired

Global contract research organization providing comprehensive drug development and laboratory ser...

Wilmington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.9BJan 2019
Warner ChilcottAcquired

Specialty pharmaceutical company

Rockaway, United States1001–5000Biotech, Healthcare
Private EquityTotal funding$3.0BJan 2004
Altos Labs

Altos Labs combines academic science and industry development to create medicines that restore ce...

San Francisco, United States501–1000Life Sciences, Biotech
Series ATotal funding$3.0BJan 2022
Syneos HealthAcquired

Integrated biopharmaceutical solutions company

Burlington, United States10001+Biotech, Healthcare
Private EquityTotal funding$3.0BMay 2017
BeiGeneIPO

BeOne Medicines develops transformative oncology medicines through rigorous science, an accelerat...

Cambridge, United States10001+Biotech, Oncology
Corporate RoundTotal funding$2.8BJan 2020
BridgeBioIPO

BridgeBio develops treatments for genetic conditions through autonomous condition-focused teams s...

San Francisco Bay Area, United States201–500Biotech, Healthcare
Growth EquityTotal funding$2.7BJul 2026

Your company? Embed this profile

Add the live badge to your site — it stays current as your funding data updates.

Vivance on Indexed.vc
<a href="https://indexed.vc/companies/vivance"><img src="https://indexed.vc/api/badge/company/vivance" alt="Vivance on Indexed.vc" width="260" height="76" /></a>